These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 27833872
1. Effects of Chemoradiation on Hearing in Patients with Head and Neck Malignancies: Experience at a Tertiary Referral Care Hospital. Jain A, Banerjee PK, Manjunath D. Indian J Otolaryngol Head Neck Surg; 2016 Dec; 68(4):456-461. PubMed ID: 27833872 [Abstract] [Full Text] [Related]
2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A. Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907 [Abstract] [Full Text] [Related]
3. Effects of Chemoradiation Therapy on Hearing in Patients with Malignancy of Head and Neck. Yadav S, Patni D, Munjal VR. Indian J Otolaryngol Head Neck Surg; 2023 Sep; 75(3):1950-1953. PubMed ID: 37636690 [Abstract] [Full Text] [Related]
4. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1393-402. PubMed ID: 15817342 [Abstract] [Full Text] [Related]
5. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819 [Abstract] [Full Text] [Related]
6. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients. Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S. J Cancer Res Ther; 2020 Mar 01; 16(3):539-545. PubMed ID: 32719264 [Abstract] [Full Text] [Related]
7. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma. Zhu W, Chen F, Li J, Wang W, Zhang H, Yang G, Zou L, Zhu Y, Yuan W, Ding H, Song X, Wang S. Acta Otolaryngol; 2019 Mar 01; 139(3):263-268. PubMed ID: 30870056 [Abstract] [Full Text] [Related]
8. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study. Apoorva KV, Vijendra Shenoy S, Athiyamaan MS, Kabekkodu S, Kshithi K, Zuturu N. Am J Otolaryngol; 2023 Mar 01; 44(4):103914. PubMed ID: 37178536 [Abstract] [Full Text] [Related]
9. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy. Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M, Nikoofar A, Mahdavi SR. Med Oncol; 2015 Jul 01; 32(7):200. PubMed ID: 26071124 [Abstract] [Full Text] [Related]
11. Factors Affecting Permanent Sensorineural Hearing Loss and Bone Conduction in Patients After Receiving Radiotherapy to the Head and Neck Region. Yücel B, Erdiş E, Bahar S, Akkaş Atasever E, Celasun MG, Altuntaş EE. Turk Arch Otorhinolaryngol; 2022 Dec 01; 60(4):212-219. PubMed ID: 37456600 [Abstract] [Full Text] [Related]
12. Risk Profiles for Sensorineural Hearing Loss in Patients with Head and Neck Cancer Receiving Cisplatin-based Chemoradiation. Shorter P, Harden F, Owen R, Panizza B, Burmeister B, Sommerville J, Mengersen K, Foote M. J Med Imaging Radiat Sci; 2017 Mar 01; 48(1):61-67. PubMed ID: 31047212 [Abstract] [Full Text] [Related]
13. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer. Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF. JAMA Otolaryngol Head Neck Surg; 2020 Feb 01; 146(2):106-112. PubMed ID: 31750863 [Abstract] [Full Text] [Related]
14. Incidence of Otitis Media with Effusion in Cases of Head and Neck Malignancies Undergoing Radiotherapy: A Prospective Observational Study. Gupta V, Dwivedi G, Sahoo L, Singh S, Patnaik U, Kumar M, Sood A. Indian J Otolaryngol Head Neck Surg; 2019 Nov 01; 71(Suppl 2):1621-1625. PubMed ID: 31750227 [Abstract] [Full Text] [Related]
15. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy. Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ. JAMA Otolaryngol Head Neck Surg; 2015 Sep 01; 141(9):810-5. PubMed ID: 26291150 [Abstract] [Full Text] [Related]
16. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer. Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA. Audiol Neurootol; 2006 Sep 01; 11(5):318-30. PubMed ID: 16983183 [Abstract] [Full Text] [Related]
17. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL. Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885 [Abstract] [Full Text] [Related]
18. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT. Arch Otolaryngol Head Neck Surg; 1997 Sep 15; 123(9):978-81. PubMed ID: 9305250 [Abstract] [Full Text] [Related]